Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Publication year range
1.
Sci Total Environ ; 882: 163592, 2023 Jul 15.
Article in English | MEDLINE | ID: mdl-37087002

ABSTRACT

Epidemiological and experimental data have associated exposure to fine particulate matter (PM2.5) with various metabolic dysfunctions and diseases, including overweight and type 2 diabetes. Adipose tissue is an energy pool for storing lipids, a necessary regulator of glucose homeostasis, and an active endocrine organ, playing an essential role in developing various related diseases such as diabetes and obesity. However, the molecular mechanisms underlying PM2.5-impaired functions in adipose tissue have rarely been explored. In this work, metabolomics based on liquid chromatography-mass spectrometry was performed to study the adverse impacts of PM2.5 exposure on brown adipose tissue (BAT) and white adipose tissue (WAT) in the diabetic mouse model. We found the effects of PM2.5 exposure by comparing the different metabolites in both adipose tissues of male db/db mice using real-ambient PM2.5 exposure. The results showed that PM2.5 exposure changed the purine metabolism in mice, especially the dramatic increase of xanthine content in both WAT and BAT. These changes led to significant oxidative stress. Then the results from real-time quantitative polymerase chain reaction showed that PM2.5 exposure could cause the production of inflammatory factors in both adipose tissues. Moreover, the increased reactive oxygen species (ROS) promoted triglyceride accumulation in WAT and inhibited its decomposition, causing increased WAT content in db/db mice. In addition, PM2.5 exposure significantly suppressed thermogenesis and affected energy metabolism in the BAT of male db/db mice, which may deteriorate insulin sensitivity and blood glucose regulation. This research demonstrated the impact of PM2.5 on the adipose tissue of male db/db mice, which may be necessary for public health.


Subject(s)
Diabetes Mellitus, Type 2 , Male , Mice , Animals , Reactive Oxygen Species/metabolism , Diabetes Mellitus, Type 2/metabolism , Xanthine/adverse effects , Xanthine/metabolism , Adipose Tissue/metabolism , Adipose Tissue, Brown , Particulate Matter/adverse effects , Energy Metabolism , Mice, Inbred C57BL
2.
Stem Cells Dev ; 21(17): 3136-46, 2012 Nov 20.
Article in English | MEDLINE | ID: mdl-22758933

ABSTRACT

Transplantation of cardiac progenitor cells (CPCs) is currently in early clinical testing as a potential therapeutic strategy. Superoxide is increased in the ischemic myocardium and poor survival of cells is one of the major limitations of cell transplantation therapy. Superoxide dismutase (SOD) levels were analyzed in c-kit-positive CPCs isolated from rat myocardium to identify their roles in protection against oxidative stress-induced apoptosis in vitro. CPCs were subjected to oxidative stress using xanthine/xanthine oxidase (XXO) and little apoptosis was detected. CPCs contained significantly higher levels of SOD1 and SOD2 as compared with adult cardiac cell types, both at the protein and activity levels. Both SOD1 and SOD2 were increased by XXO at the mRNA and protein level, suggesting compensatory adaptation. Only knockdown of SOD2 and not SOD1 with siRNA sensitized the cells to XXO-apoptosis, despite only accounting for 10% of total SOD levels. Finally, we found XXO activated Akt within 10 min, and this regulated both SOD2 gene expression and protection against apoptosis. Rat CPCs are resistant to superoxide-induced cell death, primarily through higher levels of SOD2 compared to adult cardiac-derived cells. Exposure to superoxide increases expression of SOD2 in an Akt-dependent manner and regulates CPC survival during oxidative stress.


Subject(s)
Gene Expression Regulation, Enzymologic , Myocardium/cytology , Myocytes, Cardiac/enzymology , Stem Cells/enzymology , Superoxide Dismutase/metabolism , Animals , Apoptosis , Cell Survival , Enzyme Activation , Enzyme Assays , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/enzymology , Gene Knockdown Techniques , Myocardium/enzymology , Myocytes, Cardiac/cytology , Myocytes, Cardiac/drug effects , Oxidative Stress , Phosphorylation , Proto-Oncogene Proteins c-akt/genetics , Proto-Oncogene Proteins c-akt/metabolism , Proto-Oncogene Proteins c-kit/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Rats , Rats, Sprague-Dawley , Stem Cells/cytology , Stem Cells/drug effects , Superoxide Dismutase/genetics , Superoxide Dismutase-1 , Time Factors , Transfection , Xanthine/adverse effects , Xanthine Oxidase/adverse effects
3.
Brain Res ; 1404: 63-71, 2011 Aug 02.
Article in English | MEDLINE | ID: mdl-21704983

ABSTRACT

Previously, we have published that pharmacological induction of oxidative stress causes anxiety-like behavior in rats and also is associated with hypertension in these animals. Here, we report that sub-chronic induction of oxidative stress via pharmacological induction leads to i) reduction in glyoxalase (GLO)-1 and glutathione reductase (GSR)-1 expression; ii) calpain mediated reduction of brain derived neurotrophic factor (BDNF) levels; iii) NFκB mediated upregulation of proinflammatory factors interleukin (IL)-6 and tumor necrosis factor (TNF)-α and elevated angiotensin (AT)-1 receptor levels in hippocampus, amygdala and locus coeruleus regions of the brain. Acute oxidative stress has opposite effects. We speculate that regulation of GLO1, GSR1, BDNF, NFκB and AT-1 receptor may contribute to anxiety-like behavior and hypertension in rats.


Subject(s)
Anxiety/pathology , Brain/metabolism , Gene Expression Regulation/physiology , Hypertension/pathology , Inflammation/complications , Oxidative Stress/physiology , Analysis of Variance , Animals , Anxiety/chemically induced , Brain-Derived Neurotrophic Factor/metabolism , Buthionine Sulfoximine/adverse effects , Calpain/metabolism , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay/methods , Gene Expression Regulation/drug effects , Glutathione Reductase/metabolism , Hypertension/chemically induced , Interleukin-6/metabolism , Lactoylglutathione Lyase/metabolism , Male , Oxidative Stress/drug effects , Rats , Rats, Sprague-Dawley , Receptor, Angiotensin, Type 1/metabolism , Signal Transduction/drug effects , Time Factors , Tumor Necrosis Factor-alpha/metabolism , Xanthine/adverse effects , Xanthine Oxidase/adverse effects
4.
Pediatr Nephrol ; 22(1): 132-5, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17039332

ABSTRACT

Tumor lysis syndrome is a potentially life-threatening complication of induction chemotherapy for treatment of lymphoproliferative malignancies. Serious complications of tumor lysis syndrome are rare with the preemptive use of allopurinol, rasburicase, and urine alkalinization. We report a case of oliguric acute renal failure due to bilateral xanthine nephropathy in an 11-year-old girl as a complication of tumor lysis syndrome during the treatment of T-cell acute lymphoblastic leukemia. Xanthine nephrolithiasis results from the inhibition of uric acid synthesis via allopurinol which increases plasma and urinary xanthine and hypoxanthine levels. Reports of xanthine nephrolithiasis as a cause of tumor lysis syndrome are rare in the absence of defects in the hypoxanthine-guanine phosphoribosyl transferase (HGPRT) enzyme. Xanthine nephropathy should be considered in patients who develop acute renal failure following aggressive chemotherapy with appropriate tumor lysis syndrome prophylaxis. Urine measurements for xanthine could aid in the diagnosis of patients with nephrolithiasis complicating tumor lysis syndrome. Allopurinal dosage should be reduced or discontinued if xanthine nephropathy is suspected.


Subject(s)
Acute Kidney Injury/etiology , Nephrolithiasis/complications , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Xanthine/adverse effects , Acute Kidney Injury/diagnosis , Allopurinol/adverse effects , Allopurinol/therapeutic use , Child , Enzyme Inhibitors/adverse effects , Enzyme Inhibitors/therapeutic use , Female , Humans , Nephrolithiasis/etiology , Nephrolithiasis/pathology , Tumor Lysis Syndrome/complications , Tumor Lysis Syndrome/drug therapy , Xanthine/urine
5.
Semin Neonatol ; 9(3): 239-44, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15050217

ABSTRACT

The methylxanthines aminophylline, theophylline and caffeine have been used for more than 30 years to treat apnoea of prematurity. Today, they are among the most commonly prescribed drugs in neonatal medicine. Methylxanthines reduce the frequency of idiopathic apnoea and the need for mechanical ventilation by acting as non-specific inhibitors of adenosine A(1) and A(2a) receptors. However, recent and rapidly growing research into the actions of adenosine and its receptors raises concerns about the safety of methylxanthine therapy in very preterm infants. Possible adverse effects include impaired growth, lack of neuroprotection during acute hypoxic-ischaemic episodes and abnormal behaviour. An international controlled clinical trial is underway to examine the long-term efficacy and safety of methylxanthine therapy in very low birth weight babies.


Subject(s)
Apnea/drug therapy , Central Nervous System Stimulants/adverse effects , Central Nervous System Stimulants/therapeutic use , Infant, Premature, Diseases/drug therapy , Xanthine/adverse effects , Xanthine/therapeutic use , Adenosine/therapeutic use , Heart Rate/drug effects , Humans , Infant, Newborn , Infant, Premature , Randomized Controlled Trials as Topic , Vasodilator Agents/therapeutic use
6.
Clin Exp Pharmacol Physiol ; 30(12): 958-62, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14678236

ABSTRACT

1. We have examined the effects of HR780, a novel 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on porcine endothelial cell (EC) injury induced by xanthine (X)/xanthine oxidase (XO), a source of superoxide anion. Furthermore, the effects of HR780 on platelet-derived growth factor (PDGF)-induced migration and fetal calf serum (FCS)-induced proliferation of rabbit smooth muscle cells (SMC) were investigated. 2. Probucol, at 10 micro mol/L, significantly (P < 0.001) and completely suppressed lactate dehydrogenase leakage induced by X/XO. At 10 micro mol/L, HR780 significantly (P = 0.010) inhibited X/XO-induced EC injury. 3. HR780 dose-dependently inhibited PDGF-induced SMC migration and FCS-induced SMC proliferation. The addition of mevalonate completely abolished the inhibitory effect of HR780 on SMC proliferation. Another HMG-CoA reductase inhibitor, simvastatin (0.1-100 micro mol/L), also inhibited the migration and proliferation responses as potently as HR780. In contrast, pravastatin (0.1-100 micro mol/L) did not show any effects. 4. This in vitro study provides the first evidence that HR780 protects the vascular endothelium from oxidant stress and inhibits the migration and proliferation of SMC.


Subject(s)
Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Muscle, Smooth, Vascular/drug effects , Pyridines/pharmacology , Animals , Aorta, Thoracic/cytology , Aorta, Thoracic/enzymology , Cell Division/drug effects , Cell Division/physiology , Cell Movement/drug effects , Cell Movement/physiology , Cells, Cultured , Dose-Response Relationship, Drug , Endothelial Cells/drug effects , Endothelial Cells/enzymology , Endothelial Cells/pathology , Fetal Blood/physiology , L-Lactate Dehydrogenase/antagonists & inhibitors , L-Lactate Dehydrogenase/metabolism , Male , Mevalonic Acid/pharmacology , Muscle, Smooth, Vascular/cytology , Platelet-Derived Growth Factor/antagonists & inhibitors , Platelet-Derived Growth Factor/pharmacology , Pravastatin/pharmacology , Probucol/administration & dosage , Probucol/pharmacokinetics , Rabbits , Simvastatin/pharmacology , Swine , Xanthine/adverse effects , Xanthine/antagonists & inhibitors , Xanthine/metabolism , Xanthine Oxidase/adverse effects , Xanthine Oxidase/antagonists & inhibitors , Xanthine Oxidase/metabolism
7.
J. bras. med ; 78(5): 68-80, maio 2000.
Article in Portuguese | LILACS | ID: lil-288370

ABSTRACT

Os autores revisaram as drogas, o mecanismo que desencadeia a dependência ao café; estudaram suas complicações e explanaram sobre o tratamento


Subject(s)
Coffee/adverse effects , Coffee/history , Caffeine , Caffeine/pharmacokinetics , Caffeine/metabolism , Central Nervous System Stimulants/adverse effects , Central Nervous System/drug effects , Xanthine/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...